Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab in clinical practice: managing the risks, enjoying the benefits.
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Substance Name: ONO 4641
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
TH17 cell differentiation is regulated by the circadian clock.
Bilateral idiopathic optic neuritis in pregnancy.
Vitamin D and multiple sclerosis: what is the clinical impact?
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
Parkinsonism in multiple sclerosis patients: A casual or causal association?
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.
Paraneoplastic and other autoimmune disorders of the central nervous system.
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
Pages
« first
‹ previous
…
253
254
255
256
257
258
259
260
261
…
next ›
last »